These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1737222)

  • 1. Prevention of blindness in giant cell arteritis by corticosteroid treatment.
    Myles AB; Perera T; Ridley MG
    Br J Rheumatol; 1992 Feb; 31(2):103-5. PubMed ID: 1737222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blindness in temporal arteritis despite prednisolone treatment].
    Jensen EC
    Ugeskr Laeger; 2000 May; 162(21):3052-3. PubMed ID: 10850197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Oral prednisolone 40 mg daily is not adequate for temporal arteritis once vision is affected.
    Finlay R
    BMJ; 1997 Aug; 315(7107):549. PubMed ID: 9329327
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
    Bevis T; Ratnakaram R; Smith MF; Bhatti MT
    Clin Exp Ophthalmol; 2005 Aug; 33(4):437-9. PubMed ID: 16033370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The bane of giant cell arteritis from an ophthalmological viewpoint].
    Meli B; Landau K; Gloor BP
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1821-8. PubMed ID: 9005521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatable blindness in temporal arteritis.
    Clearkin L
    Br J Ophthalmol; 1992 Jan; 76(1):63-4. PubMed ID: 1739701
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
    Kupersmith MJ; Langer R; Mitnick H; Spiera R; Spiera H; Richmond M; Paget S
    Br J Ophthalmol; 1999 Jul; 83(7):796-801. PubMed ID: 10381666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The missing picture: blindness in giant cell arteritis.
    Yates M; MacGregor AJ; Watts RA; O'Sullivan E
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-3-4. PubMed ID: 25602716
    [No Abstract]   [Full Text] [Related]  

  • 10. Giant cell arteritis update.
    Neff AG; Greifenstein EM
    Semin Ophthalmol; 1999 Jun; 14(2):109-12. PubMed ID: 10758218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bilateral amaurosis in 11 patients with giant cell arteritis confirmed by arterial biopsy].
    Wenkel H
    Klin Monbl Augenheilkd; 2001 Oct; 218(10):658-61. PubMed ID: 11706381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of giant cell arteritis].
    Dunker PJ; Ebel J
    Dtsch Med Wochenschr; 1982 Jun; 107(25):988-9. PubMed ID: 7084066
    [No Abstract]   [Full Text] [Related]  

  • 13. Giant cell (temporal) arteritis in Singapore: an occult case and the rationale of treatment.
    Cullen JF; Chan BM; Wong CF; Chew WC
    Singapore Med J; 2010 Jan; 51(1):73-7. PubMed ID: 20200780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.
    Kyle V; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):662-6. PubMed ID: 2782976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual loss in giant cell arteritis 3 weeks after steroid initiation.
    Le Goueff A; Peters J; Willcocks L; Jayne D
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30846454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid treatment in giant cell arteritis.
    Myles AB
    Br J Rheumatol; 1992 Nov; 31(11):787. PubMed ID: 1296626
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical visual loss in giant cell arteritis.
    Thystrup J; Knudsen GM; Mogensen AM; Fledelius HC
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):759-64. PubMed ID: 7747591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term corticosteroid treatment in giant cell arteritis.
    Andersson R; Malmvall BE; Bengtsson BA
    Acta Med Scand; 1986; 220(5):465-9. PubMed ID: 3812030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forehead necrosis, one of the many facades of giant cell arteritis.
    Palmer VE; Young-Zvandasara T; Vusirikala B
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25953578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranial arteritis: treatment is urgent.
    Drug Ther Bull; 1984 Feb; 22(3):11-2. PubMed ID: 6697894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.